A non-surgical treatment for knee osteoarthritis shows promise, with 80% of patients experiencing significant pain relief lasting at least a year, according to a recent study.
A groundbreaking non-surgical procedure for knee osteoarthritis is providing lasting pain relief for many patients. Researchers have found that this innovative treatment, which utilizes dissolvable gelatin particles to block excess blood vessels, significantly reduces inflammation without the need for implants.
In a clinical study involving 194 participants, 80% reported substantial reductions in knee pain that persisted for at least a year following the treatment. These findings suggest a viable alternative for millions of adults suffering from chronic joint pain who have exhausted options like pain medications or steroid injections, yet wish to avoid total knee replacement.
According to the Mayo Clinic, osteoarthritis leads to the deterioration of joint cartilage and prompts the body to develop unnecessary new blood vessels around the knee. This excess vascular growth contributes to inflammation and irritates nearby nerves, resulting in painful movement.
The procedure, known as genicular artery embolization (GAE), directly addresses these issues. By temporarily obstructing the surplus blood vessels, doctors can effectively reduce inflammation and alleviate pain-sensing nerve activity without resorting to major surgery or permanent implants.
One of the key advantages of GAE is that it employs microscopic gelatin particles that dissolve over time, leaving no foreign material in the body. If adopted widely, this technique could offer a repeatable and low-risk option for patients aiming to maintain an active lifestyle and preserve joint function for longer periods.
“For many patients with knee osteoarthritis, there is a real treatment gap today,” said Dr. Florian Nima Fleckenstein, deputy head of Interventional Radiology at Charité-Universitätsmedizin Berlin. “Our study demonstrates that GAE using rapidly resorbable gelatin-based microspheres is a safe, minimally invasive therapy that provides meaningful pain relief and functional improvement in participants with osteoarthritis-related knee symptoms for at least 12 months.”
During the GAE procedure, doctors utilize real-time X-ray guidance to navigate a thin, flexible tube into the blood vessels surrounding the knee joint. They then release tiny, dissolvable gelatin particles into specific vessels, effectively slowing excess blood flow to the inflamed areas.
Across 239 procedures performed on the 194 study participants, none experienced severe complications. Only 6.7% reported mild side effects, such as brief skin discoloration or minor bruising, which resolved without intervention.
“In our cohort, we saw a significant drop in pain and a significant increase in function, including sports and recreation and daily activity,” Fleckenstein noted. “Most importantly, their quality of life significantly increased.”
In addition to experiencing reduced pain, participants reported improvements in daily mobility. Many found it easier to walk, climb stairs, and bend, with overall quality-of-life scores more than doubling during the 12-month follow-up period.
While the results of this study are encouraging, researchers acknowledge several important limitations. Firstly, the study lacked a control group receiving a placebo or mock procedure. Without a comparison group, it is challenging to determine whether the benefits observed were due to the treatment or potential placebo effects.
Secondly, the study only tracked patients for one year. Further research is necessary to ascertain how long the pain relief typically lasts and how frequently repeat treatments may be needed.
Lastly, while GAE effectively reduces inflammation and pain, it is important to note that the procedure does not rebuild lost cartilage or reverse existing structural joint damage. Larger, randomized trials are currently underway to validate these initial findings.
Fox News Digital reached out to the study authors for additional comments.
According to Fox News, the implications of this research could reshape the treatment landscape for knee osteoarthritis, offering hope to those seeking alternatives to traditional surgical interventions.